Stay updated on Amgen Press Releases
Sign up to get notified when there's something new on the Amgen Press Releases page.

Latest updates to the Amgen Press Releases page
- Check7 days agoChange DetectedAdded multiple new press releases to the Newsroom Press Releases page, including the acquisition of Dark Blue Therapeutics, a JPMorgan Healthcare Conference presentation, the webcast and results release for 2025 fourth quarter and full-year financial results, European Commission approval of UPLIZNA for generalized myasthenia gravis, and an entry for the Citi 2026 Virtual Oncology Leadership Summit.SummaryDifference7%

- Check14 days agoChange DetectedThe Press Releases listing now omits several items: the Dark Blue Therapeutics acquisition, the JP Morgan Healthcare Conference presentation, and the 2025 financial results announcements; January–February 2026 entries are also removed.SummaryDifference5%

- Check21 days agoChange DetectedNew press releases were added: Dark Blue Therapeutics acquisition; JP Morgan Healthcare Conference presentation; webcast of 2025 Q4 and full-year results; and Q4 2025 results. Footer copyright year updated from 1996-2025 to 1996-2026.SummaryDifference5%

- Check35 days agoChange DetectedJanuary 2026 press releases were added, including AMGEN ACQUIRES DARK BLUE THERAPEUTICS, BOLSTERING ONCOLOGY PIPELINE (01.06.2026) and AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE (01.07.2026).SummaryDifference2%

- Check50 days agoChange DetectedThe Press Releases archive now includes a 2026 year option, and a substantial portion of 2025 press releases have been removed from the listing, altering the set of visible announcements.SummaryDifference22%

- Check57 days agoChange DetectedNew 2025 press release entries have been added to the Newsroom Press Releases page, including FDA approvals, quarterly results, dividends, and conference appearances.SummaryDifference52%

Stay in the know with updates to Amgen Press Releases
Enter your email address, and we'll notify you when there's something new on the Amgen Press Releases page.